Product Information

GLIPIZIDE ER 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0727 per EA under NDC 59651078105. Its NADAC has been published 168 times since Jun 7, 2023.

FDA first approved this application on May 12, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GLIPIZIDE ER 5 MG TABLET

Glipizide
$0.0727per EA

Strength

5 mg/1

NDC

59651078105

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

GLIPIZIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA206928

FDA Approved

5/12/2017

TE Code

AB

On Market Since

3/3/2023

Pharmacological Classes

Sulfonylurea Compounds
Sulfonylurea

Price Statistics

The NADAC for GLIPIZIDE ER 5 MG TABLET has been published 168 times since Jun 7, 2023, and over the history we have for it it has declined 25.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0727 per EA
All-time high$0.1018 (Dec 13, 2023)
All-time low$0.0707 (May 22, 2024)
52-week high$0.0853
52-week low$0.0727
Median price$0.0841
Average price$0.0832
Largest weekly change+24.3% (Jun 19, 2024)
Weeks tracked168
Tracking sinceJun 7, 2023

Price History

1W

-3.2%

1M

-3.2%

3M

-6.2%

6M

-4.8%

1Y

-14.7%

3Y

-15.9%

5Y

N/A

All

-25.5%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of GLIPIZIDE ER 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GLIPIZIDE ER 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0727 per EA (NDC 59651078105), effective Aug 19, 2026.

How has the price of GLIPIZIDE ER 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for GLIPIZIDE ER 5 MG TABLET has declined 25.5%. It has been tracked across 168 weekly CMS publications since Jun 7, 2023.

What are the highest and lowest recorded NADAC prices for GLIPIZIDE ER 5 MG TABLET?

Since Jun 7, 2023, the NADAC for GLIPIZIDE ER 5 MG TABLET has ranged from a low of $0.0707 (May 22, 2024) to a high of $0.1018 (Dec 13, 2023), with a median of $0.0841 per EA.

Are there cheaper alternatives to GLIPIZIDE ER 5 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLIPIZIDE 5 MG TABLET, is $0.0350 per EA — about 52% below GLIPIZIDE ER 5 MG TABLET.

Who manufactures GLIPIZIDE ER 5 MG TABLET?

GLIPIZIDE ER 5 MG TABLET (NDC 59651078105) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.